Cetalus - Key Practice Areas

Pharmaceutical Consultancy India. New market entry in the European Union. Re-engineering of US Nutraceuticals business. Industry-first evidence based promotion for specialty nutraceutical in Europe. New animal health applications for specialty nutraceutical in key international markets. Repositioning of specialty nutraceuticals as OTx for global leadership. Position extension of human nutraceutical and serious immune modulator for Quality of Life Support in companion animals undergoing chemotherapy and radiation. Quantum leap in sales and profitability with new Animal Health business strategy in Asia. Reversed price decline for European product group. Reversed sales decline for global product with new formulations. Facilitated leadership of minority Animal Health Business with strategic acquisition. Reversed profit decline for global Animal Health Business with COGS rationalization. Protected European registration and reversed Asian trade barrier for US feed supplement. Enhanced valuation of Global Animal Health business with competitive registrations.
Pilot of proprietary cosmeceutical at world's most famous luxury store in Europe. Launching specialty nutraceuticals in medical foods.

BUSINESS STRATEGY	NEW COUNTRY ENTRY - ATTRACTIVENESS, SUCCESS REQUIREMENTS, STRATEGY e.g. INDIA ENTRY
IMPLEMENTATION STRATEGY - PROJECTS MANAGEMENT	PRICING - MARKET DRIVEN, PRICE ELASTICITY MODEL
KEY ACCOUNTS MANAGEMENT	PRODUCT DEVELOPMENT AND POSITIONING
LICENSING AND ACQUISITIONS	PRODUCT, PRODUCT-LINE, MARKET PORTFOLIO PRIORITIZATION
MARKETING PROMOTION - EVIDENCE BASED MODEL	SOURCING AND COGS RATIONALIZATION
MARKETING SPENDING - POTENTIAL, RESPONSE INDICES MODEL